sibutramine has been researched along with t-226296 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alleaume, T; Balavoine, F; Cherfils, V; Jeanneton, O; Malabre, P; Revah, F; Rey, A; Seigneurin-Venin, S | 1 |
| Casper, MD; Chaki, S; Choi, J; Grottick, AJ; Han, S; Hauser, EK; Hsu, D; Kanuma, K; Kramer, B; Morgan, M; Sekiguchi, Y; Semple, G; Sengupta, D; Thomsen, W; Tran, TA; Vallar, P; Whelan, K; Zou, N | 1 |
2 other study(ies) available for sibutramine and t-226296
| Article | Year |
|---|---|
Design and synthesis of novel hydantoin-containing melanin-concentrating hormone receptor antagonists.
Topics: Animals; Chemistry, Pharmaceutical; Depression; Disease Models, Animal; Drug Design; Feeding Behavior; Hydantoins; Kinetics; Melanins; Models, Biological; Models, Chemical; Models, Molecular; Receptors, Pituitary Hormone; Receptors, Somatostatin; Structure-Activity Relationship | 2007 |
Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.
Topics: Administration, Oral; Animals; Anti-Obesity Agents; Cyclohexylamines; Eating; Humans; Male; Pyrimidines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Somatostatin; Structure-Activity Relationship; Weight Loss | 2009 |